[go: up one dir, main page]

WO2013012749A3 - Glycoprotéines humaines de la zone pellucide, leurs oligosaccharides et leurs utilisations - Google Patents

Glycoprotéines humaines de la zone pellucide, leurs oligosaccharides et leurs utilisations Download PDF

Info

Publication number
WO2013012749A3
WO2013012749A3 PCT/US2012/046748 US2012046748W WO2013012749A3 WO 2013012749 A3 WO2013012749 A3 WO 2013012749A3 US 2012046748 W US2012046748 W US 2012046748W WO 2013012749 A3 WO2013012749 A3 WO 2013012749A3
Authority
WO
WIPO (PCT)
Prior art keywords
oligosaccharides
zona pellucida
human
human zona
pellucida glycoproteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/046748
Other languages
English (en)
Other versions
WO2013012749A2 (fr
Inventor
William Shu Biu YEUNG
Philip Chi Ngong CHIU
Anne Dell
Poh-Choo PANG
Kay-Hooi Khoo
Gary Francis CLARK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Missouri Columbia
University of Missouri St Louis
Original Assignee
University of Missouri Columbia
University of Missouri St Louis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Missouri Columbia, University of Missouri St Louis filed Critical University of Missouri Columbia
Publication of WO2013012749A2 publication Critical patent/WO2013012749A2/fr
Publication of WO2013012749A3 publication Critical patent/WO2013012749A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne le diagnostic de l'infertilité humaine et plus particulièrement des procédés et des compositions qui permettent d'évaluer la capacité du sperme humain à se lier à un ovocyte humain.
PCT/US2012/046748 2011-07-15 2012-07-13 Glycoprotéines humaines de la zone pellucide, leurs oligosaccharides et leurs utilisations Ceased WO2013012749A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161572450P 2011-07-15 2011-07-15
US61/572,450 2011-07-15

Publications (2)

Publication Number Publication Date
WO2013012749A2 WO2013012749A2 (fr) 2013-01-24
WO2013012749A3 true WO2013012749A3 (fr) 2013-03-28

Family

ID=47558684

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/046748 Ceased WO2013012749A2 (fr) 2011-07-15 2012-07-13 Glycoprotéines humaines de la zone pellucide, leurs oligosaccharides et leurs utilisations

Country Status (1)

Country Link
WO (1) WO2013012749A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2784512T3 (en) 2013-03-28 2017-08-28 Förderverein Bioökonomieforschung E V (Fbf) PROCEDURE FOR PREDICTING THE FERTILITY OF A BULL BASED ON ITS EJACULATE
CA3000627A1 (fr) * 2014-09-30 2016-04-07 Dxnow Inc. Systemes et procedes de determination d'echantillons probants et d'isolement et de quantification de cellules
CN108918733B (zh) * 2018-07-28 2021-05-11 夏永刚 基于电喷雾质子化裂解定量中药三萜皂苷含量所需碰撞能的预测方法
EP3768825B1 (fr) 2018-08-24 2021-08-11 Spermosens AB Biocapteur pour l'infertilité masculine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996028169A1 (fr) * 1995-03-15 1996-09-19 Medical College Of Hampton Roads Glycoconjuges inhibiteurs de la fixation sperme-ovule chez l'homme
US20020028470A1 (en) * 1998-02-19 2002-03-07 Ke-Wen Dong Human zona pellucida protein 3 and uses thereof
US20030148930A1 (en) * 2001-08-02 2003-08-07 Ting-Fung Chi Human zona pellucida proteins and methods of their use in diagnoising male infertility

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996028169A1 (fr) * 1995-03-15 1996-09-19 Medical College Of Hampton Roads Glycoconjuges inhibiteurs de la fixation sperme-ovule chez l'homme
US20020028470A1 (en) * 1998-02-19 2002-03-07 Ke-Wen Dong Human zona pellucida protein 3 and uses thereof
US20030148930A1 (en) * 2001-08-02 2003-08-07 Ting-Fung Chi Human zona pellucida proteins and methods of their use in diagnoising male infertility

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KOZLOVSKY, P. ET AL.: "The Relative Contributions of Propulsive Forc es and Receptor-Ligand binding Forces During Early Contact between Spermato zoa and Zona Pellucida of Oocytes", JOURNAL OF THEORETICAL BIOLOGY, vol. 294, 2012, pages 139 - 143 *
PANG, P-C. ET AL.: "Human Sperm Binding Is Mediated by the Sialyl-LewisX 01 igosaccharide on the Zona Pellucida", SCIENCE, vol. 333, 23 September 2011 (2011-09-23), pages 1761 - 1764 *

Also Published As

Publication number Publication date
WO2013012749A2 (fr) 2013-01-24

Similar Documents

Publication Publication Date Title
WO2012116081A3 (fr) Procédés d'identification d'agents cosmétiques pour des compositions de soins de la peau
WO2011103584A3 (fr) Nouvelles immunoadhésines ctla4-1g
MX336682B (es) Anticuerpos contra csf-1r humanos y usos de los mismos.
WO2012140274A3 (fr) Composés
EP3470526A3 (fr) Anticorps qui se lient spécifiquement à l'alpha toxine de staphylococcus aureus et leurs procédés d'utilisation
WO2010120757A3 (fr) Régénération de tissus sans transplantation de cellules
MX2012006553A (es) Anticuerpos contra csf-1r humano y usos de los mismos.
WO2011106322A3 (fr) Biomarqueurs pour accident ischémique cérébral aigu
BR112013033661A2 (pt) inibidores de ativação de células t
WO2012056457A3 (fr) COMPOSITIONS ET PROCÉDÉS D'ACTIVATION D'EXPRESSION PAR UN ARNmi ENDOGÈNE SPÉCIFIQUE
WO2010089411A3 (fr) Anticorps pd-1 et anticorps pd-l1 et leurs utilisations
EP2841623A4 (fr) Procédés de préparation d'hydroxyde de lithium
AU2009301431A8 (en) Bispecific anti-VEGF/anti-ANG-2 antibodies
WO2011060363A3 (fr) Modulateurs des récepteurs d2 et/ou des récepteurs d3 à base de cyclohexylurée
WO2011075636A3 (fr) Épitopes et agents de liaison destinés à wise
WO2011140337A3 (fr) Leucocidines de staphylococcus aureus, compositions thérapeutiques et leurs utilisations
WO2011103490A3 (fr) Anticorps neutralisant anti-intégrine αvβ8
WO2013149111A3 (fr) Anticorps anti-tlr4 et utilisations de ceux-ci
AU2012323781A8 (en) Antibodies to CD1d
WO2013184908A3 (fr) Systèmes et procédés d'identification d'agents cosmétiques pour des compositions de soins de cheveux/cuir chevelu
WO2012109238A3 (fr) Procédés d'augmentation des réponses immunitaires à l'aide d'agents qui se lient directement à ire-1 et activent ire-1
WO2011160827A3 (fr) Nouvelles molécules inhibitrices de jnk
EP3492101A3 (fr) Agents de neutralisation de la grippe
HK1198591A1 (en) Oxmif as a diagnostic marker
BRPI1008802A2 (pt) composição, vetor e formulação farmacêutica para o uso na prevenção ou tratamento de alergia a pólen de grama por tolerização, produto, e, método in vitro para determinar se as células t reconhecem uma composição

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12815198

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12815198

Country of ref document: EP

Kind code of ref document: A2